Point of Care Testing for Infectious Diseases Market to hit US $2.2 billion by 2025 – Global Insights on Trends, Value Chain Analysis, Regulatory Framework, Drivers, and Future Prospect: Adroit Market Research

NEXT STORY
ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors
PREV STORY
Itamar Medical Reports First Quarter 2021 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aduro Biotech Announces Four Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Preliminary Phase 1 data for novel STING pathway activator ADU-S100 (MIW815) accepted for presentationBERKELEY, ...

author_avatar
NASDAQ Market News

Bavarian Nordic to Present at Jefferies 2017 Healthcare Conference in New York

COPENHAGEN, Denmark - June 1, 2017 - Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) ...

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News